Search Results 741-750 of 19280 for Myocardium

1. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

   Patients who have had a myocardial infarction within 6 months (24 weeks) prior to registration are not eligible. Patients who have class III or IV heart ...

2. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

   ... myocardial infarction within the past 6 months, or >= grade 3 cardiac arrhythmias; Patients must have undergone an electrocardiogram (EKG) within 28 days ...

3. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   ... myocardial infarction within the past 6 months; Systemic treatment, within 14 days before the first dose of MLN9708, with strong inhibitors of cytochrome ...

4. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   History of myocardial infarction or other evidence of arterial thrombotic disease (angina) * Note: Allowed only if patient has no evidence of active disease ...

5. Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma (MANTRA) - Mayo Clinic

   Myocardial infarction within 6 months;; Uncontrolled angina pectoris within 6 months;; New York Heart Association Class 3 or 4 congestive heart failure ...

6. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

   Unstable angina, myocardial infarction, or stroke within 6 months prior to the planned first dose of study treatment. Presence of inflammatory vascular ...

7. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   History of cardiac disease: congestive heart failure (CHF) > New York Heart Association (NYHA) Class II; active coronary artery disease, myocardial ...

8. Genetic Studies of Sarcomere-Based Cardiac Diseases - Zebrafish Genetics Lab: Xiaolei Xu - Mayo Clinic Research

   The hearts in pickwick embryos manifest weak cardiac contractility, thin and stretched myocardial cell morphology, and significantly reduced ventricular ...

9. A Study of TAS-120 in Patients with Advanced Solid Tumors - Mayo Clinic

   Myocardial infarction, severe/unstable angina, symptomatic congestive heart failure (New York Heart Association [NYHA] Class III or IV within the previous 2 ...

10. Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors - Mayo Clinic

    New York Heart Association Class III or IV cardiac disease, or myocardial infarction, severe unstable angina, coronary/ peripheral artery bypass graft, ...